Go to deals
Financial Services

Generalfinance S.p.A. has completed an IPO on Euronext STAR Milan

Generalfinance S.p.A. has completed an IPO on Euronext STAR Milan to strengthen its competitive positioning in the market of factoring for distressed companies, improve capital ratios and increase their turnover.

Generalfinance engages in the provision of financing solutions through the credit of trade receivables. It offers assessment to the customer portfolio or prospect, credit of trade receivables before they mature, credit administration, management and collection, and non-payment risk.

Oaklins Italy’s parent company Banca Akros acted as the global coordinator, joint bookrunner and sponsor in the IPO of Generalfinance on Euronext STAR Milan, raising a total of US$39 million, the first IPO of 2022 on the STAR segment.

Talk to the deal team

Giulio Greco

Managing Director
Milan, Italy
Oaklins Italy

Marco Valsecchi

Associate
Milan, Italy
Oaklins Italy

Nicola Biancoli

Analyst
Milan, Italy
Oaklins Italy

Related deals

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Private Equity | Financial Services

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.

Learn more
doValue has finalized a rights issue
Financial Services

doValue has finalized a rights issue

doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.

Learn more